Peptidoglycan β-1,4-glycosidic bond (PG β-1,4 bond)

The peptidoglycan β-1,4-glycosidic bond is the critical covalent linkage that alternates between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) to form the glycan backbone of the bacterial cell wall [1]. This bond provides the necessary mechanical strength to the peptidoglycan layer, allowing bacteria to withstand high internal osmotic pressure [2]. It is the specific target of lysozyme (muramidase), an essential component of the innate immune system found in human tears, saliva, and mucus [3]. Lysozyme acts by hydrolyzing this specific glycosidic linkage, which destabilizes the cell wall and results in the osmotic lysis of the bacterium [2]. While most clinical antibiotics inhibit the enzymes responsible for building these bonds, the bond itself remains a primary target for enzymatic degradation by both host defenses and certain bacteriophage-derived endolysins [4]. References: [1] NCBI Bookshelf, Medical Microbiology, 4th edition; [2] StatPearls, Biochemistry, Peptidoglycan; [3] UniProt, Lysozyme C (P00698); [4] PubMed, Bacteriophage endolysins as novel anti-infectives.

Other names

β-1,4-glycosidic linkageN-acetylmuramic acid-N-acetylglucosamine bondNAM-NAG glycosidic bondMuramidase target bond

Hydrolysis of the β-1,4-glycosidic bond between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues, leading to the degradation of the peptidoglycan layer and subsequent osmotic lysis of the bacterial cell.